• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Repligen Corporation - Common Stock (NQ:RGEN)

170.29 -2.38 (-1.38%)
Delayed Quote Updated: 4:00 PM EST, Nov 19, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 880,556
Open 173.69
Bid (Size) 170.28 (400)
Ask (Size) 170.48 (100)
Prev. Close 172.67
Today's Range 168.94 - 178.85
52wk Range 100.99 - 198.87
Shares Outstanding 55,679,964
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Repligen: 3 Key Takeaways for Long-Term Investors ↗
November 05, 2026
Services revenue is building a recurring base while capital orders suggest stronger sales ahead. 
Via The Motley Fool
Topics Earnings
News headline image
1 mid-cap stock with exciting potential and 2 facing headwinds
November 04, 2026
Mid-cap stocks have the best odds of scaling into $100 billion corporations thanks to their tested business models and large addressable markets. But the man... 
Via StockStory

Performance

52-Week Range 14.4% below 52-week high
170.29
100.9952W Low 198.8752W High
1 Week 4.8% below 1-week high
160.271W Low 178.851W High

Repligen Corporation - Common Stock (RGEN) traded between $100.99 and $198.87 over the past 52 weeks and last traded at $170.29, 14.4% below its 52-week high. Over the past week it ranged between $160.27 and $178.85.

Past 12 Months
+1.5%
-4.8%
-5.5%
+50.2%
+3.6%
+9.8%
1W +$2.50
1M -$8.59
3M -$10.00
6M +$56.92
YTD +$5.94
1Y +$15.21

RGEN was +9.8% over the past year, +50.2% over six months, +3.6% year to date, +1.5% in the last week.

12 Months vs Market
RGEN
+9.8%
DIA
+6.3%
SPY
+8.0%
QQQ
+7.5%
IWM
+13.2%

Over the past 12 months RGEN returned +9.8% versus DIA (Dow) +6.3%, SPY (S&P 500) +8.0%, QQQ (Nasdaq 100) +7.5% and IWM (Russell 2000) +13.2%.

Volume & Liquidity 0.74× 3-mo avg
Today 880,556 3-mo avg 1.2M
1W
807.1K
1M
1.2M
3M
1.2M
6M
1.1M
YTD
1.1M
1Y
1.0M

RGEN most recently traded 880,556 shares against a 3-month average daily volume of 1.2M.

More News

Read More
News headline image
5 must-read analyst questions from Repligen’s Q3 earnings call
October 30, 2026
Via StockStory
Topics Earnings
News headline image
RGEN Q3 deep dive: margin headwinds and BioLife integration shape improved full-year outlook
October 30, 2026
Via StockStory
Topics Artificial Intelligence
Repligen Corp (NASDAQ:RGEN) Combines Strong Growth with a Constructive Technical Setup ↗
September 05, 2026
Via Chartmill
Repligen (NASDAQ:RGEN) Combines Strong Growth with a Promising Technical Breakout Setup ↗
July 30, 2026
Via Chartmill
News headline image
Repligen (RGEN) Q3 2026 Earnings Call Transcript ↗
October 27, 2026
Via The Motley Fool
Topics Earnings
News headline image
What Repligen (RGEN) Said on Its Q3 Earnings Call ↗
October 27, 2026
Via MarketBeat
Topics Earnings
News headline image
Repligen (NASDAQ:RGEN) exceeds Q3 2026 expectations, full-year outlook slightly exceeds expectations
October 27, 2026
Via StockStory
Repligen (NASDAQ:RGEN) Rallies as Quality Stock Delivers Earnings Beat ↗
July 28, 2026
Via Chartmill
News headline image
Repligen (RGEN) Q3 earnings report preview: what to look for
October 25, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Azenta, Myriad Genetics, Moderna, Repligen, and PacBio Shares Plummet, What You Need To Know
October 16, 2026
Via StockStory
Topics Bonds Economy
News headline image
Why Freshworks Stock Bumped Higher Today ↗
October 06, 2026
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
3 Healthcare Stocks That Concern Us
October 02, 2026
Via StockStory
News headline image
3 Reasons to Avoid RGEN and 1 Stock to Buy Instead
September 09, 2026
Via StockStory
Topics Stocks
News headline image
1 Profitable Stock on Our Buy List and 2 We Brush Off
August 28, 2026
Via StockStory
News headline image
3 High-Flying Stocks with Warning Signs
August 24, 2026
Via StockStory
Topics Supply Chain
News headline image
3 Hyped Up Stocks We Keep Off Our Radar
August 21, 2026
Via StockStory
News headline image
Unpacking Q2 Earnings: Repligen (NASDAQ:RGEN) In The Context Of Other Drug Development Inputs & Services Stocks
August 16, 2026
Via StockStory
News headline image
2 Growth Stocks to Add to Your Roster and 1 We Avoid
August 13, 2026
Via StockStory
Topics Credit Cards
News headline image
Why Repligen (RGEN) Stock Is Up Today
July 28, 2026
Via StockStory
Topics Artificial Intelligence
News headline image
Repligen Q2 Earnings Call Highlights ↗
July 28, 2026
Via MarketBeat
Topics Earnings
Which stocks are gapping on Tuesday? ↗
July 28, 2026
Via Chartmill
News headline image
Repligen (NASDAQ:RGEN) Posts Better-Than-Expected Sales In Q2 CY2026
July 28, 2026
Via StockStory
News headline image
Repligen (RGEN) Q2 Earnings: What To Expect
July 26, 2026
Via StockStory

Frequently Asked Questions

Is Repligen Corporation - Common Stock publicly traded?
Yes, Repligen Corporation - Common Stock is publicly traded.
What exchange does Repligen Corporation - Common Stock trade on?
Repligen Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Repligen Corporation - Common Stock?
The ticker symbol for Repligen Corporation - Common Stock is RGEN on the Nasdaq Stock Market
What is the current price of Repligen Corporation - Common Stock?
The current price of Repligen Corporation - Common Stock is 170.29
When was Repligen Corporation - Common Stock last traded?
The last trade of Repligen Corporation - Common Stock was at 11/19/26 04:00 PM ET
What is the market capitalization of Repligen Corporation - Common Stock?
The market capitalization of Repligen Corporation - Common Stock is 9.48B
How many shares of Repligen Corporation - Common Stock are outstanding?
Repligen Corporation - Common Stock has 9B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap